Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Micromet

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Metastatic dissemination of cancer cells is a very complex process. It includes the intravasation of cells into the metastatic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
  • Asher Mullard
  • Nature Reviews Drug Discovery
  • 2014
  • Corpus ID: 10991700
were initially developed by Micromet, which was acquired by Amgen in 2012 for US$1.16 billion. Financial analysts expect sales of… Expand
Is this relevant?
2012
2012
volume 30 number 4 APrIl 2012 nature biotechnology “It’s pioneering technology based on a simple, elegant concept,” enthuses… Expand
  • table 1
Is this relevant?
2011
2011
Abstract 252 Adult patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL) have a dismal prognosis with… Expand
Is this relevant?
2008
2008
OBJECTIVES To evaluate the effect of microwave disinfection on the flexural strength and Vickers hardness of 4 autopolymerized… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
AIM OF THE STUDY The aim of this study was to evaluate the effect of at-home (Opalesence/Dr. kit 15%, Ultradent, Products, Inc… Expand
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2005
2005
Objective To evaluate the microhardness of dentine underlying glass ionomer restorations made with Atraumatic Restorative… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2003
2003
PURPOSE Over the past 5 years, several clinical studies on a total of approximately 2500 patients have shown that the… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2003
2003
OBJECTIVES This prospective study was performed to examine whether tumour cells are detectable in the tumour draining vein of… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2002
2002
Abstract Micromet is an emerging young German biotech company developing next-generation antibody-based pharmaceuticals. One of… Expand
Is this relevant?